In a proactive measure, pharmaceutical company Mylan has initiated a nationwide voluntary recall of specific lots of EpiPen and EpiPen Jr. devices, citing potential defects. These devices are crucial for individuals who suffer from severe allergic reactions, which makes this recall a significant step for ensuring user safety.
Mylan’s announcement reveals that, while the likelihood of a defect is minimal, the decision to recall was made “out of an abundance of caution.” This action follows reports from outside the U.S. regarding devices that failed to activate due to a component issue from a supplier. Notably, both reports originated from a lot that had already been recalled. This recall expands to include additional lots to ensure safety. According to Mylan’s statement, “The incidence of the defect is extremely rare and testing and analysis across the potentially impacted lots has not identified any units with a defect.”
If the defect is present, it could cause an EpiPen to malfunction, requiring excessive force to activate or failing to work entirely, which could delay critical treatment during severe allergic reactions. The recall specifically targets lots of EpiPen and EpiPen Jr. distributed from December 17, 2015, to July 1, 2016. A chart detailing the affected U.S. lots and their expiration dates is available on Mylan’s website.
This recall isn’t the first time Mylan has faced scrutiny over EpiPen pricing, as the company’s significant price hike in the previous summer sparked widespread outrage. Following public backlash, Mylan reduced the cost from an astonishing $600 to $300, although manufacturing costs remain around $30. While the EpiPen still remains high-priced, it is reassuring to see Mylan prioritize consumer safety.
If you have an EpiPen or EpiPen Jr. device, especially those kept at school for your child, it’s essential to verify that they are not included in the recalled lots. For those affected, Mylan’s website provides guidance on obtaining replacements. Consumers are advised to retain their existing pens until new ones are issued.
For more on related topics, you might find our post on home insemination kit helpful. For those looking to enhance fertility, check out this fertility booster for men, which can provide additional support. Also, if you are exploring pregnancy options, Healthline offers excellent resources on in vitro fertilization.
In summary, Mylan’s voluntary recall of EpiPen and EpiPen Jr. devices reflects their commitment to user safety, despite the low risk of defects. Consumers are encouraged to verify their devices and follow Mylan’s instructions for replacements.